| Similar Articles |
|---|
 |
Chemistry World
July 8, 2015
Phillip Broadwith |
Thermo Fisher to buy Alfa Aesar chemical supplies The acquisition complements its existing Fisher Scientific chemicals supply segment, and will be integrated with its laboratory products and services portfolio.   |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
Fisher Scientific Reels In a Deal A fair price and impressive market leverage give this merger between Fisher Scientific and Thermo Electron a better-than-average chance. Shareholders, take note. |
Chemistry World
May 10, 2006
Katharine Sanderson |
Leading Lab Suppliers Merge Analytical instrument firm Thermo Electron and chemical manufacturer Fisher Scientific announced a merger, aiming to become the leading provider of laboratory products and services in the health sciences industry. |
The Motley Fool
October 26, 2007
Brian Orelli |
This Just In: Mergers Do Indeed Lower Costs As the anniversary integration between Thermo Electron and Fisher Scientific approaches next week, Thermo Fisher Scientific announced third-quarter results that demonstrated how the integration is having a nice effect on the bottom line. |
The Motley Fool
October 26, 2011
Tim Beyers |
Thermo Fisher Scientific Shares Plunged: What You Need to Know Shares of Thermo Fisher Scientific fell more than 10% in early trading and closed off almost that much after lowering full-year earnings and revenue guidance. |
CIO
July 27, 2012
Kim S. Nash |
How Thermo Fisher Mines Customer Feedback to Improve Service Thermo Fisher Scientific overhauled its customer feedback system to allow it to be more responsive to current customers and to take advantage of emerging markets |
The Motley Fool
May 2, 2006
Stephen D. Simpson |
Still Fishing for Value at Fisher At the right price, this would be an interesting play on health care and biomedical research. Investors, take note. |
The Motley Fool
February 14, 2006
Stephen D. Simpson |
Looking for a Hook at Fisher Scientific Growth and market share are great, but return on invested capital tells the tale in the end. Investors, think twice before putting your money with this one. |
The Motley Fool
November 9, 2005
Stephen D. Simpson |
Fishing for Value at Fisher Even with today's earnings-induced jump, there still might be some value here at researcher Fisher Scientific. Investors, take note. |
The Motley Fool
July 21, 2011
Seth Jayson |
Why the Future Looks Bright for Thermo Fisher Scientific Although Thermo Fisher Scientific shows inventory growth that outpaces revenue growth, the company may also display positive inventory divergence, suggesting that management sees increased demand on the horizon. |
Chemistry World
April 19, 2013
Sarah Houlton |
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. |
The Motley Fool
October 28, 2009
Brian Orelli |
The Waters Aren't Flowing. Yet. Not unlike its products that turn ugly mixtures into purer products, Waters turned an ugly top line into an acceptable earnings growth in the third quarter. |
The Motley Fool
August 16, 2007
Brian Orelli |
More Drugmaker Growth Without the FDA All that high-tech lab equipment has to come from somewhere. Here's how investors can benefit from it, too. |
The Motley Fool
February 7, 2008
Brian Orelli |
Invitrogen Integrates After a rough 2006 in which it struggled to integrate its acquisitions, Invitrogen used 2007 to show why it made all of its purchases. |
Chemistry World
January 8, 2014
Phillip Broadwith |
Thermo Fisher to sell three analytical divisions to GE Healthcare GE will take over Thermo's cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013. |
The Motley Fool
February 8, 2010
Brian Orelli |
An Earnings Surprise of an Unusual Kind Illumina beats management's own preliminary revenue announcement. |
CFO
January 10, 2007
Roy Harris |
The Year of Living Strategically While private-equity bids got lots of attention, some public-company mergers aimed to remake their industries in 2006. |
Chemistry World
May 18, 2015
Andy Extance |
$13.8bn Danaher bid wins Pall auction US-based conglomerate Danaher has agreed to acquire filtration, separation and purification provider Pall. |
Bio-IT World
March 2007 |
Briefs Metabolomics Resources... LIMS Collaboration... Biomarker Collaboration... Analysis Update... |
The Motley Fool
January 6, 2009
Brian Orelli |
Boston Scientific Gets Gussied Up Boston Scientific is buying it's current partner, Ireland-based Labcoat. |
BusinessWeek
January 22, 2007
Aaron Pressman |
Homeland Security 2.0 Five years after September 11, a new wave of smarter high-tech tools is coming to market. |
The Motley Fool
May 25, 2007
Tom Taulli |
STARLIMS' Dim Reception The laboratory software developer's growth prospects weren't enough for IPO investors. |
Food Engineering
February 26, 2007 |
Industry & People Coffee Pacifica names vice president... Sweet Success Enterprises appoints senior vice president... National Food Laboratory adds services... etc. |
IndustryWeek
January 1, 2009
Jonathan Katz |
Thermo Fisher Scientific: IW Best Plants Profile 2008 Empowering the Workforce: Employee engagement leads the way at Thermo Fisher Scientific's Marietta, Ohio, operations. |
Bio-IT World
February 11, 2005
Salvatore Salamone |
Tackling ADME/Tox Workflow Lab techniques: Thermo's turnkey system includes a software suite to speed throughput and smooth logistics. The goal, Thermo says, is to industrialize the in vitro ADME/Tox process, a frequent bottleneck in drug development. |
The Motley Fool
May 23, 2006
Stephen D. Simpson |
Agilent's Increasing Agility The company's restructuring efforts seem to be paying off. Investors, perhaps it is time to get curious. |
Investment Advisor
June 2007 |
What Does He Like? Ken Fisher has more than an intellectual curiosity about smaller advisory firms: He's also interested in buying them. So what are the kinds of firms he's interested in? |
The Motley Fool
April 5, 2010
Selena Maranjian |
Outsourcing Never Left This disturbing trend can also be profitable. |
The Motley Fool
September 3, 2009
Mike Pienciak |
Bottled Water Batters the Blue Chips The recession hasn't gone down easy for the bottled water business. |
The Motley Fool
March 15, 2011
Cindy Johnson |
Dell Board Member Resigns: What Does She Know That You Don't? The positive read on the resignation is ... umm, don't see one. |
Military & Aerospace Electronics
August 2005
John McHale |
Thermo releases monitoring system for nuclear plants ViewPoint, a remote monitoring software platform, provides real-time personnel and area monitoring during routine and outage operations in the nuclear power industry. |
Investment Advisor
March 2008
James J. Green |
One Down, How Many to Go? Ken Fisher's the biggest RIA out there, but his firm just got a little bigger by acquiring a much smaller RIA. It's likely the first of many. |
The Motley Fool
April 19, 2010
Jennifer Schonberger |
optionsXpress CEO on the Year Ahead optionsXpress CEO David Fisher says that his company is on track as options trading gets bigger. |
National Defense
August 2006
Robert H. Williams |
Mini Device Pinpoints Nuclear Threats A pager-sized device that has been introduced by Thermo Electron not only detects and identifies specific nuclear threats, but also transmits this information in real time to command centers. |
The Motley Fool
August 3, 2010
Rex Moore |
The 15 Best Values in Pharma and Biotech Low multiples plus low risk equals compelling value. |
The Motley Fool
February 22, 2011
Jared Cummans |
Tuesday's ETF to Watch: Medical Devices Fund Medtronic reports earnings today. |
The Motley Fool
January 15, 2010
Selena Maranjian |
Warning: Your Mutual Fund Might Disappear Which could actually be a good thing. |
CFO
July 1, 2004
Alix Nyberg |
A Matter of Emphasis Regulation G was supposed to end the abuses of pro forma reporting. Has it succeeded? |
The Motley Fool
May 26, 2011
Andrew Tonner |
Does Agilent Technologies Deserve a Spot in Your Portfolio? Let's take a look at Agilent Technologies and some of its closest peers. |
The Motley Fool
July 21, 2004 |
When "Pro Forma" Is Bad Forma Don't let a company you own fool you with "pro forma" numbers. They're gussied-up numbers that companies would prefer you focus on instead of less attractive numbers that are often more accurate representations of their health or performance. |
Fast Company
September 2001
Christine Canabou |
Simplicity by Design Nine years ago, the fast life was slowing down fashion designer Eileen Fisher, and her work-life balance was out of whack. Fisher took to heart the principle that her company was founded on: Simplicity is more than just a smart design principle. It's a sane life principle... |
The Motley Fool
May 15, 2006
S.J. Caplan |
There WILL Be a Quiz: Weekly Markets Recap Wall Street was not good to most mothers and others. Have you been paying attention? Find out with our capital markets roundup and investors' quiz. |
Registered Rep.
November 1, 2006
Cheryl Winokur Munk |
The Heretic Kenneth Fisher, a global money manager and longtime Forbes columnist, is a proponent of the closed shop: He runs discretionary separate accounts for institutions and high-net-worth retail investors. Fisher farms out nothing. |
Bio-IT World
June 2005 |
News Blast Storage Solution... Day to Data... Direct Service... Kendro Acquired... |
CFO
September 1, 2006
Don Durfee |
Buy It Back, and Then? Share repurchases could fuel a surging M&A market as buyers use the stock to make acquisitions. |
The Motley Fool
May 10, 2006
Stephen D. Simpson |
A Test Maker Faces a Test of Its Own Beckman Coulter management seems to be tackling its challenges openly, but they're challenges nonetheless. Is the stock a buy? |
| Knowledge@Wharton |
Pro Forma Earnings Reports: A Deceptive View of Performance The Securities and Exchange Commission is concerned with a widespread corporate habit -- the growing practice of issuing "pro forma" earnings reports that tend to paint a rosy picture of company results... |
The Motley Fool
February 15, 2006
Stephen D. Simpson |
A Play on the Building Blocks of R&D Sigma-Aldrich might be suitable for those looking to play biological R&D without picking a specific pharma or biotech stock. |
CFO
Edward Teach & Tim Reason |
Lies, Damn Lies, and Pro Forma Pro forma earnings reports may be a cause du jour of reformers, but CFOs aren't about to back down from issuing them... |
